Article Text
Editorials
The role of baroreflex activation therapy in sympathetic modulation for the treatment of resistant hypertension
Statistics from Altmetric.com
Footnotes
-
Competing interests Dr. Bisognano has received research grants and honoraria from CVRx, the manufacturer of the Rheos and Neo systems and serves as a consultant and member of scientific advisory boards for CVRx. Minimal assistance with diagrams was obtained from CVRx.
-
Ethics approval The clinical trials summarised in this editorial were all approved by the appropriate local institutional review boards and, if necessary, ethics boards.
-
Provenance and peer review Commissioned; internally peer reviewed.